Kerudi Healthcare Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 19-12-2024
- Paid Up Capital ₹ 4.40 Cr
as on 19-12-2024
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 17.30 Cr
as on 19-12-2024
- Revenue 18.28%
(FY 2022)
- Profit 144.24%
(FY 2022)
- Ebitda 34.09%
(FY 2022)
- Net Worth 73.70%
(FY 2022)
- Total Assets -0.13%
(FY 2022)
About Kerudi Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.40 Cr.
The company has closed loans amounting to ₹17.30 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Somashekhar Kerudi, Sunita Kerudi, Narayan Muniswamy, and Four other members serve as directors at the Company.
- CIN/LLPIN
U85100KA2012PTC062083
- Company No.
062083
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jan 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bagalkot, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kerudi Healthcare?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Somashekhar Kerudi  | Managing Director | 22-Mar-2012 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunita Kerudi | Director | 22-Mar-2012 | Current |
| Narayan Muniswamy | Director | 21-Mar-2016 | Current |
| Kshamata Kerudi | Director | 21-Mar-2016 | Current |
| Chandrashekhar Kerudi | Director | 21-Mar-2016 | Current |
| Anasuya Kerudi | Director | 16-Jan-2012 | Current |
| Basavaraj Kerudi | Director | 16-Jan-2012 | Current |
Financial of Kerudi Healthcare.
Kerudi Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 18.28% increase. The company also saw a substantial improvement in profitability, with a 144.24% increase in profit. The company's net worth Soared by an impressive increase of 73.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kerudi Healthcare?
In 2020, Kerudi Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Corporation Bank Creation Date: 27 Sep 2013 | ₹17.30 Cr | Satisfied |
How Many Employees Work at Kerudi Healthcare?
Kerudi Healthcare has a workforce of 118 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kerudi Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kerudi Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
